跳至主要内容
临床试验/NCT07273058
NCT07273058招募中不适用

Effect of High-Intensity Interval Training Intervention on Post-Stroke Fatigue in Chronic Stroke Survivors: A Pilot Randomized Clinical Trial

The Hong Kong Polytechnic University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Eligibility rate (%)

研究概览

简要总结

This study aims to investigate the effect of high-intensity interval training (HIIT) on fatigue severity among individuals with chronic stroke. Participants will be randomly assigned to the HIIT group, the moderate-intensity continuous training (MICT) group, or the stretching group (active control). Each group will participate in supervised exercise sessions three times per week over a 12-week period, totaling 36 sessions. Outcome assessments will be conducted at baseline, mid-intervention (week 6), post-intervention (week 12), and follow-up (week 20). The primary outcome will be fatigue severity. Secondary outcomes will include inflammatory biomarkers and additional health-related indicators.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of 40-80 years;
  • a history of ischemic stroke resulting in unilateral limb impairment 6-60 months prior to consent to participate in the pilot trial;
  • a stable medical condition;
  • a subjective feeling of fatigue, defined as a period of apparent fatigue, decreased energy, increased need for rest, or fatigue out of proportion to physical activity for at least 2 weeks during the past month;
  • ability to communicate with the investigators and lack of significant cognitive deficits;
  • able to walk for 10 meters with or without a walking aid.

排除标准

  • An FSS score of < 4 (20);
  • other neurological conditions;
  • other musculoskeletal comorbidities that would prevent safe participation in exercises;
  • a medical diagnosis of significant cardiovascular, pulmonary, or metabolic disease(s);
  • signs or symptoms indicative of significant cardiovascular, pulmonary, or metabolic disease(s) during the previous 3 months;
  • severe lower limb spasticity (Ashworth Scale score ≥ 3);
  • Botulinum toxin use in the affected lower limb within the past six months;
  • current or previous use of drugs intended to resolve post-stroke fatigue;
  • active engagement in other stroke rehabilitation trials.

结局指标

主要结局

Eligibility rate (%)

时间窗: Through study completion, an average of 12 weeks.

Compliance with HIIT (%)

时间窗: From baseline to week 12

Recruitment rate (number of participants per month)

时间窗: Through study completion, an average of 12 weeks.

Fidelity to the HIIT protocol (%)

时间窗: From baseline to week 12

Adverse events (number of events)

时间窗: From baseline to week 12

Retention of the intervention (%)

时间窗: From baseline to week 12

Acceptability (qualitative)

时间窗: At week 12

次要结局

  • Multidimensional Fatigue Inventory (MDI)(Blinded assessors will conduct evaluations at baseline, week 12 , and week 20.)
  • Short Form-36 Health Survey (SF-36)(Blinded assessors will conduct evaluations at baseline, week 6, and week 12.)
  • Fatigue Severity Scale (FSS)(Blinded assessors will conduct evaluations at baseline, week 12 , and week 20.)
  • Inflammatory biomarkers(Blinded assessors will conduct evaluations at baseline, week 6, and week 12.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr HUANG Mei Zhen

Assistant professor

The Hong Kong Polytechnic University

研究点 (1)

Loading locations...

相似试验